At close: December 20 at 4:00:00 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -3.38 | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 |
---|---|---|
EPS Est. | -0.15 | -0.1 |
EPS Actual | -0.25 | -0.32 |
Difference | -0.1 | -0.22 |
Surprise % | -69.82% | -220.00% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
NRXS | -- | -- | -- | -- |
S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
AVBP ArriVent BioPharma, Inc.
26.09
+1.72%
GDTC CytoMed Therapeutics Limited
2.5600
+3.64%
MLYS Mineralys Therapeutics, Inc.
12.34
+4.31%
NLSPW NLS Pharmaceutics AG
0.0112
-41.05%
ANL Adlai Nortye Ltd.
2.1600
-3.57%
PHVS Pharvaris N.V.
19.57
+2.95%
GNLX Genelux Corporation
2.2700
+3.65%
TSBX Turnstone Biologics Corp.
0.4911
+6.41%
BNTC Benitec Biopharma Inc.
11.41
-6.24%
NRX.V NurExone Biologic Inc.
0.7000
-2.78%